Category: Pharmaceutical Outcomes and Policy
Hansen, Roth Co-Investigators on Grant
May 14, 2007Two professors from the UNC School of Pharmacy’s Division of Pharmaceutical Outcomes and Policy are co-investigators on a one-year, $140,000 grant from the School of Medicine’s “Investments for the Future” Project. Richard Hansen, PhD, and Mary Roth, PharmD, MHS, will be part of a project that aims to enlist pharmacist intervention to reduce drug therapy problems, such as incorrect usage, in older psychiatric patients. The focus of the project will be to establish a pharmacist-run clinic in psychiatry. The project leader is Lea C. Watson, MD, MPH, an assistant professor in the Department of Psychiatry. The funding is for pilot … Read more
Murray Study: Heart-Failure Patients Benefit from Pharmacist Care
May 14, 2007Heart-failure patients take their medicine more reliably when under the care of a pharmacist, resulting in fewer emergency-room visits and hospital stays and lower health-care costs, according to a study led by Michael D. Murray, PhD, the Mescal S. Ferguson Distinguished Professor at the School. According to the American Heart Association, more than five million people in the United States are in various stages of heart failure with total health-care costs exceeding $29 billion. The study, published in the June 2007 issue of the Annals of Internal Medicine, studied 314 low-income patients with heart failure. The participants were studied as … Read more
Farley Receives Pfizer Grant
May 4, 2007Joel Farley, PhD, an assistant professor at the UNC School of Pharmacy, has received a two-year, $130,000 grant from Pfizer Inc. for his research on the effect of Medicaid prescription restrictions on patients with mental illnesses. Farley, who is in the Division of Pharmaceutical Outcomes and Policy, received the 2007 Scholars Grant in Health Policy. The supporting sponsor on the grant is Susan Blalock, PhD, Farley’s mentor and an associate professor in the division. The grant is part of Pfizer’s Medical & Academic Partnerships program, which is intended to support the career development of junior faculty. Farley will use his … Read more
Hansen Receives NIH Career Development Award
June 14, 2006Richard Hansen, PhD, was named a Clinical Research Scholar under the UNC Multidisciplinary Clinical Research Career Development Program. This award is part of the National Institutes of Health Roadmap Initiative and will provide salary and research funding over five years to support Hansen’s work in the multidisciplinary management of depression in primary care. Hansen’s project “The Quality of Antidepressant Use in Primary Care” focuses on understanding and improving adherence to antidepressants in non-psychiatric settings. The UNC MCRCDP is designed to re-engineer the clinical research enterprise by training new clinical research leaders, which is a key component of the NIH Roadmap. Eugene … Read more
Maciejewski Appointed Associate Professor
June 2, 2006Matthew Maciejewski, PhD, has been appointed associate professor in the Division of Pharmaceutical Outcomes and Policy. Maciejewski comes to the School of Pharmacy from the University of Washington in Seattle, where he was an associate professor at the School of Public Health and Community Medicine. Maciejewski received a BS in Foreign Service from Georgetown University in 1991 and a PhD in health services and research policy from the University of Minnesota in 1998. From 1991-1993 he worked as a research assistant for the Board of Governors of the Federal Reserve System in Washington D.C. From 1993-1998 Maciejewski was a research … Read more
Roth Receives NIH Career Development Award
May 25, 2006Mary Roth, PharmD, MHS, assistant professor in the Division of Pharmaceutical Outcomes and Policy, was awarded a Mentored Patient-Oriented Research Career Development Award from the National Institute on Aging. Roth will receive $699,170 over five years to support her project “Improving the Quality of Medication Use in Older Adults.” The goal of the project is to design, implement, and evaluate a medication management program to improve the quality of medication use for older adults. The purpose of the NIH Mentored Patient-Oriented Research Career Development Award is to support the career development of investigators who have made a commitment to focus their research endeavors … Read more
Sleath Awarded Travel Grant to Help Glaucoma Patients in India
May 25, 2006Betsy Sleath, PhD, associate professor in the Division of Pharmaceutical Outcomes and Policy, has been awarded a travel grant from the UNC Partnership in Global Health to support her proposal “Improving Treatment Adherence of Glaucoma Patients in Southern India.” In 2004 Sleath and Alan Robin, MD, associate professor of ophthalmology at Johns Hopkins University, developed a a survey to examine problems that patients were having using glaucoma medications. Sleath and Robin recently modified the survey for use at the Aravind Eye Care System in southern rural India. The Aravind Eye Care System offers essentially free eye care to individuals at five eye clinics and hospitals in southern India. Despite the free … Read more
Roth Receives Defriese Award
April 17, 2006Mary Roth, PharmD, MHS, has received the 2006 Gordon H. Defriese Career Development in Aging Research Award. The award, given by the UNC Institute on Aging, is presented each year to one UNC faculty or staff member and one doctoral student who demonstrates outstanding promise in aging research. Roth is an assistant professor in the Division of Pharmaceutical Outcomes and Policy in the School of Pharmacy and a research assistant professor in the Division of Geriatric Medicine in the School of Medicine. She has served as co-investigator on numerous aging research projects that focus particular attention to optimizing medication use in older adults with chronic diseases. Roth … Read more
Study: Second-Generation Antidepressants Very Similar
December 14, 2005Researchers at the University of North Carolina at Chapel Hill have found evidence that many second-generation antidepressants, despite differences in drug classification and cost, offer patients very similar benefits and only minimal differences in risks. Second-generation antidepressants include selective serotonin reuptake inhibitors (SSRIs) and other drugs that selectively affect the activity of neurotransmitters. A paper published in the Annals of Internal Medicine, led by Richard A. Hansen, PhD, assistant professor in the School of Pharmacy , examined the effects of ten commonly prescribed second-generation antidepressants, including Prozac, Zoloft, Wellbutrin , and Paxil . The study examined the role of these … Read more
Gordon Liu Hosts Nobel Laureate Forum at 2005 China Economic Summit
December 14, 2005Gordon Liu, PhD, hosted a Nobel laureate forum at the 2005 China Economics Summit. The forum was held in the People’s Great Hall in Beijing on May 24. Liu is an associate professor of health economics in the Division of Pharmaceutical Policy and Evaluative Sciences. He is also as the president of the Chinese Economists Society.